Neurotrophic Keratitis

Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Neurotrophic Keratitis Subjects

A Multicenter, Randomized, Vehicle-Controlled, Double-Masked to Open-Label Study to Evaluate the Safety and Efficacy of Lacripep in Subjects With Neurotrophic Keratitis

A Study of STSP-0902 Ophthalmic Solution in Healthy Subjects

A Study Comparing KB801 Verse Placebo in Patients With Stage 2 or 3 Neurotrophic Keratitis

QST for Corneal Nerve Function

DEFENDO Long Term Follow-up Study in Stage 1 NK Patients

Study to Evaluate OXERVATE® in Patients With Stage 1 Neurotrophic Keratitis

Corneal Neurotization vs. Cenergermin for Neurotrophic Keratitis: A Pilot Study

A Phase II Study of STSP-0902 Ophthalmic Solution in Patients With Neurotrophic Keratitis

REC 0/0559 Eye Drops for Treatment of Moderate and Severe Neurotrophic Keratitis in Adult Patients

Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Autoimmune Disease

DOMPE -MT Neurotrophic Keratitis

Corneal Nerves After Treatment With Cenegermin

Efficacy and Safety of Plasma Rich in Growth Factors (PRGF-Endoret) Eye-drops in the Treatment of Neurotrophic Keratitis

Differences in Corneal Structure and Function in Patients With Sjogrens vs. Non-Sjogrens Dry Eye

Open-label Trial to Evaluate Efficacy and Safety of rhNGF on Corneal Thickness Via AS-OCT in Neurotrophic Keratitis

Assessment of the Initial Efficacy and Safety of BRM424 Ophthalmic Solutions in Patients With Neurotrophic Keratitis

Evaluation of Safety and Efficacy of rhNGF in Patients With Stage 2 and 3 Neurotrophic Keratitis.

OCT Evaluation of Neurotrophic Ulcer Following Treatment With Oxervate

Topical Insulin Drops for the Treatment of Neurotrophic Keratopathy.